Newsroom

Verantos presents on artificial intelligence and real-world evidence at the Economist’s Cell and Gene Therapy Summit

Conferences

Verantos was invited to speak in two sessions at the Economist’s Cell and Gene Therapy Summit, April 15-16, in Brussels. In one panel, along with representatives from NICE and HTAi, Verantos will speak to the use of RWE in cell and gene therapy. Dan Riskin will provide the closing keynote on what the future might hold as AI meets innovative therapies.

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.